NIH-funded research Career grant

Multidimensional view of how regulatory T cells behave in kids with severe viral pneumonia

Official title: Multidimensional analysis of the regulatory T cell response in children with severe viral pneumonia

Funded at Lurie Children's Hospital of Chicago · NIH-11401190 · Data updated 2026-11-12

A doctor-scientist program aims to understand how regulatory T cells influence recoveries from severe viral pneumonia in children, with results that could lead to better treatments.

More Pneumonia research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionLurie Children's Hospital of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2026
Award (this year)$163,080
NIH project number5K08HL176208-03
Project IDNIH-11401190 on NIH RePORTER

Who could benefit from this research

Could help

Children under 5 years old who have experienced severe viral pneumonia and are at risk for lung injury.

Less likely to help

The study is focused on understanding mechanisms; direct benefit to individual patients is not guaranteed during the research.

What this research studies

This project uses a mouse model that mirrors how severe viral pneumonia affects very young children to study immune responses over time. It focuses on regulatory T cells and how they control inflammation and repair in the lungs after infection. The research will analyze immune signals, cell interactions, and lung healing processes to identify why children have prolonged lung injury and slower recovery. The ultimate goal is to uncover targets for therapies that could hasten recovery and reduce long-term lung problems in kids who get severe viral pneumonia.

Why it matters

Potential benefit: If successful, findings could guide development of therapies that lessen lung injury and speed recovery in children with severe viral pneumonia.

How similar studies have gone: Previous animal studies showed juvenile mice have prolonged lung inflammation despite viral clearance, supporting the relevance of this model.

Where this research is happening

  • Lurie Children's Hospital of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Prigge, Andrew — Lurie Children's Hospital of Chicago
  • Study coordinator: Prigge, Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.